Bempedoic Acid Production Cost Reports

The report provides a detailed analysis essential for establishing a bempedoic acid production plant. It encompasses all critical aspects necessary for bempedoic acid production, including the cost of bempedoic acid production, bempedoic acid plant cost, bempedoic acid production costs, and the overall bempedoic acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a bempedoic acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Bempedoic Acid is a cholesterol-lowering pharmaceutical compound that is mainly used in the treatment of high levels of LDL cholesterol, often referred to as “bad cholesterol.” It is commonly prescribed as an oral drug to reduce low-density lipoprotein (LDL) cholesterol in adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease. It is given to patients with cardiovascular risk or who cannot tolerate statin medications or need extra help along with statins to manage their cholesterol. It works by blocking an enzyme involved in cholesterol production in the liver, which helps reduce cholesterol buildup in the bloodstream. It is usually taken by mouth in tablet form and can be used together with other lipid-lowering treatments. Moreover, it is often used to lower the risk of heart attacks, strokes, and the need for heart procedures like stents or bypass surgery in those at high cardiovascular risk.

The market for bempedoic acid is mainly driven by its application as an oral medication that helps lower cholesterol levels in the blood, which boosts its demand in the medical sector. Its application as an antilipemic drug in the treatment of people with a genetic condition called familial hypercholesterolemia and for long-term cholesterol management also promotes its demand in the pharmaceutical industry. Its involvement as a drug in combination with other lipid-lowering drugs, such as ezetimibe, to improve overall cholesterol control further adds to its demand in the medical and pharmaceutical industries. Its usage as a cholesterol-lowering agent in patients with known atherosclerotic cardiovascular disease who are intolerant of conventional statin therapy significantly drives its demand in the healthcare sector.

Its demand in the medical and healthcare sectors for preventing heart-related complications like heart attacks and strokes by supporting healthier blood lipid levels largely contributes to its market expansion. Industrial bempedoic acid procurement is shaped by factors such as the availability and cost of raw materials, regulatory approvals in major markets, and compliance with evolving pharmaceutical production standards. Moreover, production innovations, supplier consistency, environmental protocols, and optimised supply chain strategies also play a crucial role in its global procurement operations.

Raw Material for Bempedoic Acid Production

According to the bempedoic acid production plant project report, the major raw materials for bempedoic acid production include ethyl isobutyrate, alkyl bromide, methanesulfonyl isocyanate, isopropionic acid, and sodium borohydride.

Production Process of Bempedoic Acid

The extensive bempedoic acid production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of bempedoic acid begins with ethyl isobutyrate, which undergoes alkylation with an alkyl bromide, followed by a Finkelstein reaction to convert the intermediate into the corresponding alkyl iodide. Then, this iodide is reacted with methanesulfonyl isocyanate under alkaline conditions to promote dialkylation and form an isonitrile intermediate, which is not isolated but directly carried forward. The reaction mixture is treated with isopropionic acid under acidic conditions, and careful pH adjustment leads to the formation of a ketone intermediate in high yield. Further, this ketone is reduced using sodium borohydride, and the resulting product is subjected to saponification to obtain the crude active pharmaceutical ingredient. Finally, the crude product is purified, followed by a series of crystallisation steps, which result in the formation of bempedoic acid as the desired product.

Bempedoic Acid is a first-in-class adenosine triphosphate-citrate lyase (ACL) inhibitor that appears as a white-to-off-white crystalline powder at room temperature. The molecular formula of the compound is C19H36O5, and its molar mass is 344.49 g/mol. It has a density of approximately 1.045 g/cm³, and its melting point is in the range of 87–92 degrees Celsius. The boiling point of the compound is approximately 506.5 degrees Celsius. It is commercially available under the brand name Nexletol. It is slightly soluble in chloroform and methanol, and it should be stored under refrigeration at 0–4 degrees Celsius to maintain its stability. The compound is classified as a non-hazardous chemical for shipping purposes and is generally considered to have a favourable safety profile. However, the most common adverse effects associated with its therapeutic use include hyperuricemia (elevated blood levels of uric acid), pain in the limbs, tendon rupture, muscle spasms, and anaemia. It is recommended to handle the compound with appropriate protective measures in a labouratory setting, including the use of gloves and eye protection.